
Dr. Michael Wasef
Medical Director, Board Certified Internal Medicine
Wasef Health Provider Network

Zepbound® is the brand name, FDA approved tirzepatide injection from Eli Lilly and Company, approved for chronic weight management in eligible adults. It acts on two hormone pathways, GLP-1 and GIP, rather than one.
Zepbound® is the brand name, FDA approved tirzepatide injection from Eli Lilly and Company, approved for chronic weight management in eligible adults. It acts on two hormone pathways, GLP-1 and GIP, rather than one.
Zepbound® through Bodi Envi starts at $1,399. The final figure depends on the dose your provider prescribes, and you see it before you pay.
The brand product in sealed manufacturer packaging, not a compounded preparation
FDA approved for chronic weight management in adults who meet the labelled criteria
A once weekly injection, with the dose set and adjusted by your provider.
A self pay price. Bodi Envi does not bill insurance for it, there is no membership fee, and completing the assessment costs nothing.
Compounded tirzepatide is a separate, lower cost program and is not the same as Zepbound®.
Answer a few quick questions about your lifestyle and health. We’ll create a plan that’s personalized to your journey.
We’ll use your responses to build a treatment plan that fits your lifestyle and delivers real results.
Fast, free, and discreet delivery right to your door. We work with accredited pharmacies that uphold the highest standards of quality and safety.


Bodi Envi is LegitScript certified.
LegitScript certification provides independent verification applicable to healthcare merchants that meet LegitScript’s certification standards.
Verify Bodi Envi’s certificationZepbound® is the brand product, dispensed in sealed manufacturer packaging. A licensed provider decides whether it is appropriate for you, and you see the price before you pay.
Board-certified providers who create every personalized plan.

Medical Director, Board Certified Internal Medicine
Wasef Health Provider Network

Clinical Provider, Board Certified Family Medicine
Wasef Health Provider Network

Nurse Practitioner, Board Certified
Wasef Health Provider Network

Nurse Practitioner, Board Certified
Wasef Health Provider Network

Bodi Envi was founded by husband and wife team Ashley and Shaun Padgett, whose journey in weight loss and wellness spans more than 16 years. As owners of two successful brick-and-mortar clinics in Florida, Padgett Medical Center has earned over 1,600 Google reviews with an average rating of 4.9 stars.
Over the years, they've had the privilege of caring for thousands of patients face-to-face, building real relationships, listening closely, and watching lives change.
Ashley understands the struggle personally. Living with PCOS, she has lost 52 pounds with the help of GLP-1 medications. Shaun has also experienced the journey firsthand, losing 30 pounds with GLP-1 support.
As telemedicine began to grow, Ashley and Shaun saw both an opportunity and a gap. While virtual care made access easier, something essential was missing, the personal connection, the listening, and the genuine care that comes from an in-person visit. They knew patients deserved more.
That belief became Bodi Envi.
Their vision was simple but powerful: to bring the same high-touch service, trust, and expertise they were known for in their clinics into the telemedicine space, without sacrificing quality or compassion.
Equally important was quality. Bodi Envi is committed to offering high-quality, U.S.-sourced medications, ensuring consistency, efficiency, and peace of mind. No shortcuts. No compromises. No bots.
Your health isn’t one-size-fits-all. Get a personalized treatment plan built to match your body and your goals.
Yes. This is the brand product from Eli Lilly and Company in sealed manufacturer packaging. It is not a compounded preparation.
The FDA has approved Zepbound® for chronic weight management in eligible adults.
Pricing starts at $1,399 and varies by the dose your provider prescribes. You see the exact figure before you pay, and completing the assessment costs nothing.
No. This is a self pay price and Bodi Envi does not bill insurance for it.
No. Bodi Envi is a telehealth platform. You complete an online health assessment and a licensed provider with Wasef Health, PC reviews it and determines whether treatment is appropriate.
Bodi Envi is a telehealth platform and is not a pharmacy. If a provider prescribes Zepbound®, the prescription is sent to one of Bodi Envi's partner pharmacies, which dispenses it in sealed manufacturer packaging and ships it to your address. Clinical services are provided by Wasef Health, PC, 5260 78th Ave N, PO Box 1697, Pinellas Park, Florida 33780.
Bodi Envi provides the telehealth platform. Licensed healthcare providers evaluate patients and independently decide whether treatment is appropriate. Wasef Health, PC provides the clinical services. Partner pharmacies dispense and ship. Bodi Envi does not compound, dispense, prescribe or manufacture, and is not a medical practice or a pharmacy.
Completing an assessment does not guarantee a prescription. If you are not qualified, a refund will be issued.
Zepbound® is the brand product made by Eli Lilly and Company and approved by the FDA. Bodi Envi's Personalized Compounded Tirzepatide is prepared for an individual patient by a licensed compounding pharmacy, is not FDA approved and is not the same product. The compounded program costs less. A licensed provider advises which, if either, suits your health history.
Zepbound® is approved by the FDA for chronic weight management in eligible adults.
This page is general information, not medical advice. Individual results vary and are not typical. Treatment is not guaranteed. Talk to your provider about the risks and benefits, including known side effects, before starting any GLP-1 medication. For a medical emergency, call 911 or seek immediate emergency care.
Zepbound® is a registered trademark of Eli Lilly and Company. Bodi Envi is not affiliated with, endorsed by or sponsored by Eli Lilly and Company. Trademarks are used only to identify the product a provider may prescribe.